Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Chirurgie (Heidelberg, Germany)|February 10, 2026
[Current concepts of total neoadjuvant therapy for rectal cancer]Claus Rödel, Maximilian Fleischmann, Markus Diefenhardt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 11, 2023
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapyKristina Viktorsson, Thorsten Rieckmann, Maximilian Fleischmann, et al.
JAMA Network Open|October 30, 2023
Overall Survival After Treatment Failure Among Patients With Rectal CancerMarkus Diefenhardt, Daniel Martin, Maximilian Fleischmann, et al.
JAMA Network Open|September 12, 2024
Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal CancerMarkus Diefenhardt, Daniel Martin, Ralf-Dieter Hofheinz, et al.
Cancers|November 9, 2024
Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter?Markus Diefenhardt, Daniel Martin, Maximilian Fleischmann, et al.
Nature Reviews. Clinical Oncology|May 13, 2025
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancerFranz Rödel, Maximilian Fleischmann, Markus Diefenhardt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 26, 2025
Advantages of 3D printed patient-individual moulds in brachytherapy for facial skin cancerJörg Licher, Julia Achenbach, Janett Köhn, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 21, 2022
Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approachMaximilian Fleischmann, Markus Diefenhardt, Martin Trommel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2021
Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trialMarkus Diefenhardt, Ethan B Ludmir, Ralf-Dieter Hofheinz, et al.
Pageof 4